Abstract
SummaryIndications for the use of RATS vary between the facilities but correspond as far as possible to other minimally invasive surgical findings. In general, RATS is currently a therapeutic option for the management of early-stage NSCLC without mediastinal lymph node involvement in oncological surgery, although depending on the planned intervention and the surgical facility, hilar lymph node involvement may be accepted
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
